MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

20 Oct 2022 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release today tilted ‘Glenmark becomes the First Company in India   to launch Teneligliptin + Dapagliflozin Fixed Dose Combination, for Adults with Type 2 Diabetes, having Comorbidities’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..